454 related articles for article (PubMed ID: 12168065)
41. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
43. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
44. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
45. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
46. Scintigraphic evaluation of two cases with alveolar soft part sarcoma.
Ohta H; Ishii M; Endo K; Konishi J; Kotoura Y; Yamamuro T; Torizuka K
Ann Nucl Med; 1988 Nov; 2(2):89-93. PubMed ID: 2856319
[TBL] [Abstract][Full Text] [Related]
47. The clinical usefulness of (99m)Tc-Tetrofosmin scintigraphy in the diagnosis of lung neoplasmas and mediastinal lymphoid node involvement.
Huang D; Zhao F; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):608-12. PubMed ID: 18846350
[TBL] [Abstract][Full Text] [Related]
48. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
49. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
50. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
51. Technetium-99m-tetrofosmin imaging of lung cancer: relationship with histopathology.
Takekawa H; Shinano H; Tsukamoto E; Koseki Y; Ikeno T; Miller F; Kawakami Y
Ann Nucl Med; 1999 Apr; 13(2):71-5. PubMed ID: 10355949
[TBL] [Abstract][Full Text] [Related]
52. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
53. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
54. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
[TBL] [Abstract][Full Text] [Related]
55. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
56. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
[TBL] [Abstract][Full Text] [Related]
57. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
[TBL] [Abstract][Full Text] [Related]
58. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
Axelsson R; Bach-Gansmo T; Castell-Conesa J; McParland BJ;
Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic and prognostic value of 99mTc-tetrofosmin scintigraphy in maxillofacial flaps.
Aigner RM; Schultes G; Sorantin E
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):197-201. PubMed ID: 12552336
[TBL] [Abstract][Full Text] [Related]
60. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]